Multisystem inflammatory syndrome in children – A serious emerging syndrome

Abstract

Objective: The objective of the study was to determine the clinical features, treatment received, and outcomes of severely ill children with multisystem inflammatory syndrome in children (MIS-C). Methods: The study was a retrospective observation carried out at a pediatric intensive care unit in a tertiary care hospital. The baseline history, investigations, treatment received, and outcomes of the disease in 14 critically ill children, who were diagnosed with MIS-C, were surveyed from October 2020 to January 2022. Results: There were 14 children who were diagnosed with MIS-C. All children received intensive care treatment and 7 children received a combination of steroid therapy and intravenous immunoglobulin. Out of 14 children, 12 of them survived and 2 expired. Conclusion: For children who are diagnosed with MIS-C, the outcome was good if detected early and treated on time.

Keywords

• immunoglobulin
• multisystem inflammatory syndrome
• steroid therapy